These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An ATP-sensitive potassium (KATP) channel opener, nicorandil, lowers the threshold for ischemic preconditioning in barbital-anesthetized dogs. Mizumura T; Saito S; Ozawa Y; Kanmatsuse K; Gross GJ Heart Vessels; 1997; Suppl 12():175-7. PubMed ID: 9476575 [TBL] [Abstract][Full Text] [Related]
3. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. Gross GJ; Pieper GM; Warltier DC J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Kersten JR; Schmeling TJ; Hettrick DA; Pagel PS; Gross GJ; Warltier DC Anesthesiology; 1996 Oct; 85(4):794-807; discussion 27A. PubMed ID: 8873550 [TBL] [Abstract][Full Text] [Related]
6. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. Auchampach JA; Maruyama M; Cavero I; Gross GJ J Pharmacol Exp Ther; 1991 Dec; 259(3):961-7. PubMed ID: 1762089 [TBL] [Abstract][Full Text] [Related]
7. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114 [TBL] [Abstract][Full Text] [Related]
8. Monophosphoryl lipid A attenuates myocardial stunning in dogs: role of ATP-sensitive potassium channels. Elliott GT; Mei DA; Gross GJ J Cardiovasc Pharmacol; 1998 Jul; 32(1):49-56. PubMed ID: 9676720 [TBL] [Abstract][Full Text] [Related]
9. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits. Das B; Sarkar C; Karanth KS Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221 [TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium. Farber NE; Gross GJ J Pharmacol Exp Ther; 1989 Jan; 248(1):39-43. PubMed ID: 2536431 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological evidence for a role of ATP-dependent potassium channels in myocardial stunning. Auchampach JA; Maruyama M; Cavero I; Gross GJ Circulation; 1992 Jul; 86(1):311-9. PubMed ID: 1301066 [TBL] [Abstract][Full Text] [Related]
12. [Cardioprotective effects of K(ATP) channel opener nicorandil during ischemia/ reperfusion in dogs]. Feng L; Qiu J; Ma J; Huang XB; Cha DG; Bin JP Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):157-60. PubMed ID: 15760526 [TBL] [Abstract][Full Text] [Related]
13. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia. Nakae I; Quan L; Sugimoto Y; Tsutamoto T; Kinoshita M J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993 [TBL] [Abstract][Full Text] [Related]
14. Effect of nicorandil on post-ischaemic contractile dysfunction in the heart: roles of its ATP-sensitive K+ channel opening property and nitrate property. Iwamoto T; Miura T; Urabe K; Itoya M; Shimamoto K; Iimura O Clin Exp Pharmacol Physiol; 1993 Sep; 20(9):595-602. PubMed ID: 8222340 [TBL] [Abstract][Full Text] [Related]
16. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Yao Z; Gross GJ Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542 [TBL] [Abstract][Full Text] [Related]
17. Comparison of KRN2391 with nicorandil and nifedipine on canine coronary blood flow: antagonism by glibenclamide. Ogawa N; Fukata Y; Kaneta S; Jinno Y; Fukushima H; Nishikori K J Cardiovasc Pharmacol; 1992 Jul; 20(1):11-7. PubMed ID: 1383619 [TBL] [Abstract][Full Text] [Related]
18. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model. Lamping KA; Warltier DC; Hardman HF; Gross GJ J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374 [TBL] [Abstract][Full Text] [Related]
19. The ATP-dependent potassium channel: an endogenous cardioprotective mechanism. Yao Z; Gross GJ J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S28-34. PubMed ID: 7898105 [TBL] [Abstract][Full Text] [Related]
20. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit. Hale SL; Kloner RA J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]